The Push for Generics Challenges Manufacturers

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-07-02-2003, Volume 27, Issue 7

Biotech firms face new issues as FDA weighs policies to streamline generic-drug approvals and reduce patent disputes.

Related Content:

Quality SystemsRegulatory WatchGeneric DrugsDosage FormsPharmaceutical Technology-07-02-2003
Susan Schniepp of Regulatory Compliance Associates Explores the Impact of QMS on Quality Maturity (INTERPHEX 2024)
Keynote Session Highlights Importance of Process Validation and Data Integrity (INTERPHEX 2024)
FDA Establishes Center for Clinical Trial Innovation